Mark D. Myslinski

Plus aucun poste en cours

Profil

Mark D.
Myslinski formerly worked at Rapid Pathogen Screening, Inc., as President & Chief Executive Officer, Redpath Partners, Inc., as President & Chief Executive Officer, Interscope Technologies, Inc., as President & Chief Executive Officer, Helomics Corp., as Chief Executive Officer, CytoVas LLC, as Chief Executive Officer & Director, MDxHealth SA, as Independent Non-Executive Director from 2012 to 2015, Hologic, Inc., as Senior Vice President & GM-Diagnostics, Johnson & Johnson, as Vice President-Ortho Clinical Diagnostics Unit in 2013, Veridex LLC, as Vice President & General Manager from 2011 to 2013, Saladax Biomedical, Inc., as Senior Vice President & Chief Commercial Officer in 2013, Ortho-Clinical Diagnostics, Inc., as Vice President, and Kew, Inc., as Chief Commercial Officer.
Mr. Myslinski received his undergraduate degree from Moravian College and Masters Business Admin degree from The Ohio University.

Anciens postes connus de Mark D. Myslinski

Sociétés	Poste	Fin
MDXHEALTH SA	Directeur/Membre du Conseil	05/10/2015
CytoVas LLC	Directeur Général	-
Kew, Inc.	Corporate Officer/Principal	-
Saladax Biomedical, Inc.	Directeur des opérations	12/03/2013
Rapid Pathogen Screening, Inc.	President	-